Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis

<p>Abstract</p> <p>Background</p> <p>We demonstrated that a Chinese herbal formula, which we refer to as RCM-101, developed from a traditional Chinese medicine formula, reduced nasal and non-nasal symptoms of seasonal allergic rhinitis (SAR). The present study in primar...

Full description

Bibliographic Details
Main Authors: McPhee Sarah, Thien Frank CK, Story David F, Xue Charlie CL, Lenon George B, Li Chun G
Format: Article
Language:English
Published: BMC 2007-02-01
Series:Chinese Medicine
Online Access:http://www.cmjournal.org/content/2/1/2
id doaj-2b858eca462646a7a832dabd756cd1b6
record_format Article
spelling doaj-2b858eca462646a7a832dabd756cd1b62020-11-25T00:38:28ZengBMCChinese Medicine1749-85462007-02-0121210.1186/1749-8546-2-2Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitisMcPhee SarahThien Frank CKStory David FXue Charlie CLLenon George BLi Chun G<p>Abstract</p> <p>Background</p> <p>We demonstrated that a Chinese herbal formula, which we refer to as RCM-101, developed from a traditional Chinese medicine formula, reduced nasal and non-nasal symptoms of seasonal allergic rhinitis (SAR). The present study in primary and cultured cells was undertaken to investigate the effects of RCM-101 on the production/release of inflammatory mediators known to be involved in SAR.</p> <p>Methods</p> <p>Compound 48/80-induced histamine release was studied in rat peritoneal mast cells. Production of leukotriene B<sub>4 </sub>induced by the calcium ionophore A23187 was studied in porcine neutrophils using an HPLC assay and lipopolysaccharide-stimulated prostaglandin E<sub>2 </sub>production was studied in murine macrophage (Raw 264.7) cells by immune-enzyme assay. Expression of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) was determined in Raw 264.7 cells, using western blotting techniques.</p> <p>Results</p> <p>RCM-101 (1–100 μg/mL) produced concentration-dependent inhibition of compound 48/80-induced histamine release from rat peritoneal mast cells and of lipopolysaccharide-stimulated prostaglandin E<sub>2 </sub>release from Raw 264.7 cells. Over the range 1 – 10 μg/mL, it inhibited A23187-induced leukotriene B<sub>4 </sub>production in porcine neutrophils. In addition, RCM-101 (100 μg/mL) inhibited the expression of COX-2 protein but did not affect that of COX-1.</p> <p>Conclusion</p> <p>The findings indicate that RCM-101 inhibits the release and/or synthesis of histamine, leukotriene B<sub>4 </sub>and prostaglandin E<sub>2 </sub>in cultured cells. These interactions of RCM-101 with multiple inflammatory mediators are likely to be related to its ability to reduce symptoms of allergic rhinitis.</p> http://www.cmjournal.org/content/2/1/2
collection DOAJ
language English
format Article
sources DOAJ
author McPhee Sarah
Thien Frank CK
Story David F
Xue Charlie CL
Lenon George B
Li Chun G
spellingShingle McPhee Sarah
Thien Frank CK
Story David F
Xue Charlie CL
Lenon George B
Li Chun G
Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis
Chinese Medicine
author_facet McPhee Sarah
Thien Frank CK
Story David F
Xue Charlie CL
Lenon George B
Li Chun G
author_sort McPhee Sarah
title Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis
title_short Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis
title_full Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis
title_fullStr Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis
title_full_unstemmed Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis
title_sort inhibition of release of inflammatory mediators in primary and cultured cells by a chinese herbal medicine formula for allergic rhinitis
publisher BMC
series Chinese Medicine
issn 1749-8546
publishDate 2007-02-01
description <p>Abstract</p> <p>Background</p> <p>We demonstrated that a Chinese herbal formula, which we refer to as RCM-101, developed from a traditional Chinese medicine formula, reduced nasal and non-nasal symptoms of seasonal allergic rhinitis (SAR). The present study in primary and cultured cells was undertaken to investigate the effects of RCM-101 on the production/release of inflammatory mediators known to be involved in SAR.</p> <p>Methods</p> <p>Compound 48/80-induced histamine release was studied in rat peritoneal mast cells. Production of leukotriene B<sub>4 </sub>induced by the calcium ionophore A23187 was studied in porcine neutrophils using an HPLC assay and lipopolysaccharide-stimulated prostaglandin E<sub>2 </sub>production was studied in murine macrophage (Raw 264.7) cells by immune-enzyme assay. Expression of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) was determined in Raw 264.7 cells, using western blotting techniques.</p> <p>Results</p> <p>RCM-101 (1–100 μg/mL) produced concentration-dependent inhibition of compound 48/80-induced histamine release from rat peritoneal mast cells and of lipopolysaccharide-stimulated prostaglandin E<sub>2 </sub>release from Raw 264.7 cells. Over the range 1 – 10 μg/mL, it inhibited A23187-induced leukotriene B<sub>4 </sub>production in porcine neutrophils. In addition, RCM-101 (100 μg/mL) inhibited the expression of COX-2 protein but did not affect that of COX-1.</p> <p>Conclusion</p> <p>The findings indicate that RCM-101 inhibits the release and/or synthesis of histamine, leukotriene B<sub>4 </sub>and prostaglandin E<sub>2 </sub>in cultured cells. These interactions of RCM-101 with multiple inflammatory mediators are likely to be related to its ability to reduce symptoms of allergic rhinitis.</p>
url http://www.cmjournal.org/content/2/1/2
work_keys_str_mv AT mcpheesarah inhibitionofreleaseofinflammatorymediatorsinprimaryandculturedcellsbyachineseherbalmedicineformulaforallergicrhinitis
AT thienfrankck inhibitionofreleaseofinflammatorymediatorsinprimaryandculturedcellsbyachineseherbalmedicineformulaforallergicrhinitis
AT storydavidf inhibitionofreleaseofinflammatorymediatorsinprimaryandculturedcellsbyachineseherbalmedicineformulaforallergicrhinitis
AT xuecharliecl inhibitionofreleaseofinflammatorymediatorsinprimaryandculturedcellsbyachineseherbalmedicineformulaforallergicrhinitis
AT lenongeorgeb inhibitionofreleaseofinflammatorymediatorsinprimaryandculturedcellsbyachineseherbalmedicineformulaforallergicrhinitis
AT lichung inhibitionofreleaseofinflammatorymediatorsinprimaryandculturedcellsbyachineseherbalmedicineformulaforallergicrhinitis
_version_ 1725297395055460352